What Delcath Systems Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 4 |
| Sells | 0 | 0 |
| Total trades | 2 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 3,627 | 36,246 |
| Disposed | 27,502 | 27,502 |
| Net activity | −23,875 | +8,744 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | Director | Oct 13 | Other Transaction · J | −27,502 | — | — | 3,389,593 |
| Rosalind Advisors, Inc. | Director | Oct 13 | Derivative Conversion · C | +3,627 | — | — | 3,417,095 |
| Pennell Sandra | Chief Financial Officer | Mar 06 | Open-market buy · P | +5,533 | $9.04 | +$50K | 77,018 |
| Michel Gerard J | CHIEF EXECUTIVE OFFICER | Mar 02 | Open-market buy · P | +11,200 | $8.96 | +$100K | 342,034 |
| Sylvester John Richard | Director | Nov 21 | Open-market buy · P | +4,386 | $8.89 | +$39K | 14,936 |
| Michel Gerard J | CHIEF EXECUTIVE OFFICER | Nov 11 | Open-market buy · P | +11,500 | $8.53 | +$98K | 330,834 |
| Vukovic Vojo | CHIEF MEDICAL OFFICER | Jun 12 | Exercise / conversion · M | +42,000 | $4.78 | +$201K | 168,882 |
| Rosalind Advisors, Inc. | Director | May 05 | In/At-money Exercise · X | +400,000 | $10.00 | +$4M | 3,413,468 |
| Salamon Steven A J | Director | May 05 | In/At-money Exercise · X | +400,000 | $10.00 | +$4M | 3,413,468 |
| Aharon Gil | Director | May 05 | In/At-money Exercise · X | +400,000 | $10.00 | +$4M | 3,413,468 |
| Rosalind Advisors, Inc. | Director | Dec 24 | Derivative Conversion · C | +250,000 | $10.00 | +$2.5M | 3,013,468 |
| Salamon Steven A J | Director | Dec 24 | Derivative Conversion · C | +250,000 | $10.00 | +$2.5M | 3,013,468 |
| Aharon Gil | Director | Dec 24 | Derivative Conversion · C | +250,000 | $10.00 | +$2.5M | 3,013,468 |
| Michel Gerard J | CHIEF EXECUTIVE OFFICER | Oct 22 | Exercise / conversion · M | +16,666 | $6.00 | +$100K | 319,334 |
| Rosalind Advisors, Inc. | Director | Apr 18 | Derivative Conversion · C | +991,615 | — | — | 2,763,468 |
| Rosalind Advisors, Inc. | Director | Apr 18 | In/At-money Exercise · X | +619,946 | $0.01 | +$6.2K | 2,763,468 |
| Salamon Steven A J | Director | Apr 18 | Derivative Conversion · C | +991,615 | — | — | 2,732,586 |
| Salamon Steven A J | Director | Apr 18 | In/At-money Exercise · X | +619,946 | $0.01 | +$6.2K | 2,732,586 |
| Aharon Gil | Director | Apr 18 | Derivative Conversion · C | +991,615 | — | — | 2,681,271 |
| Aharon Gil | Director | Apr 18 | In/At-money Exercise · X | +619,946 | $0.01 | +$6.2K | 2,681,271 |
Loading...
